Supporting this model, we observed that ER- tumours with simultaneous low TGFB and high IL12 activity had significantly better outcome and that stratification based on the combination of these two pathways provided a better prognostic classification than those based on single pathways (Figures 6 &7). This evidence concerns the gene TGFB1 and neoplasm.